Genetics of amyotrophic lateral sclerosis

Handbook of Clinical Neurophysiology

Volumn 4, Issue C, 2004, Pages 169-186

  Dewil, M ^a   Andersen, P M ^b   Van Den Bosch, L ^a   Robberecht, W ^a  

^a UNIVERSITY HOSPITALS LEUVEN   (Belgium)

^b UMEÅ UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 77957099429     PISSN: 15674231     EISSN: None     Source Type: Book Series    
DOI: 10.1016/S1567-4231(04)04008-0     Document Type: Article

References (175)

1. Abe K., Pan L.H., Watanabe M., Kato T., and Itoyama Y. Induction of nitrotyrosine-like immunoreactivity in the lower motor neuron of amyotrophic lateral sclerosis. Neurosci. Lett 199 (1995) 152-154
2. Aguirre T., Van Den Bosch L., Goetschalckx K., Tilkin P., Mathijs G., Cassiman J.J., and Robberecht W. Increased sensitivity of fibroblasts from amyotrophic lateral sclerosis patients to oxidative stress. Ann. Neurol 43 (1998) 452-457
3. Ahmad-Annuar A., Shah P., Hafezparast M., Hummerich H., Witherden A.S., Morrison K.E., Shaw P.J., Kirby J., Warner T.T., Crosby A., Proukakis C., Wilkinson P., Orrell R.W., Bradley L., Martin J.E., and Fisher E.M. No association with common Caucasian genotypes in exons 8, 13 and 14 of the human cytoplasmic dynein heavy chain gene (DNCHC1) and familial motor neuron disorders. Amyotroph. Lateral Scler. Other Motor Neuron Disord 4 (2003) 150-157
4. Al-Chalabi A., Enayat Z.E., Bakker M.C., Sham P.C., Ball D.M., Shaw C.E., Lloyd C.M., Powell J.F., and Leigh P.N. Association of apolipoprotein E epsilon 4 allele with bulbar-onset motor neuron disease. Lancet 347 (1996) 159-160
5. Al-Chalabi A., Andersen P.M., Chioza B., Shaw C., Sham P.C., Robberecht W., Matthijs G., Camu W., Marklund S.L., Forsgren L., Rouleau G., Laing N.G., Hurse P.V., Siddique T., Leigh P.N., and Powell J.F. Recessive amyotrophic lateral sclerosis families with the D90A SOD1 mutation share a common founder: evidence for a linked protective factor. Hum. Mol. Genet 7 (1998) 2045-2050
6. Al-Chalabi A., Andersen P.M., Nilsson P., Chioza B., Andersson J.L., Russ C., Shaw C.E., Powell J.F., and Leigh P.N. Deletions of the heavy neurofilament subunit tail in amyotrophic lateral sclerosis. Hum. Mol. Genet 8 (1999) 157-164
7. Al-Chalabi A., Scheffler M.D., Smith B.N., Parton M.J., Cudkowicz M.E., Andersen P.M., Hayden D.L., Hansen V.K., Turner M.R., Shaw C.E., Leigh P.N., and Brown Jr. R.H. Ciliary neurotrophic factor genotype does not influence clinical phenotype in amyotrophic lateral sclerosis. Ann. Neurol 54 (2003) 130-134
8. Andersen P.M. Genetics of sporadic ALS. Amyotroph. Lateral Scler. Other Motor Neuron Disord 2 Suppl. 1 (2001) S37-S41
9. Andersen P.M., Nilsson P., Ala-Hurula V., Keranen M.L., Tarvainen I., Haltia T., Nilsson L., Binzer M., Forsgren L., and Marklund S.L. Amyotrophic lateral sclerosis associated with homozygosity for an Asp90Ala mutation in CuZn-superoxide dismutase. Nat. Genet 10 (1995) 61-66
10. Andersen P.M., Forsgren L., Binzer M., Nilsson P., Ala-Hurula V., Keranen M.L., Bergmark L., Saarinen A., Haltia T., Tarvainen I., Kinnunen E., Udd B., and Marklund S.L. Autosomal recessive adult-onset amyotrophic lateral sclerosis associated with homozygosity for Asp90Ala CuZn-superoxide dismutase mutation. A clinical and genealogical study of 36 patients. Brain 119 (1996) 1153-1172
11. Andersen P.M., Nilsson P., Keranen M.L., Forsgren L., Hagglund J., Karlsborg M., Ronnevi L.O., Gredal O., and Marklund S.L. Phenotypic heterogeneity in motor neuron disease patients with CuZn-superoxide dismutase mutations in Scandinavia. Brain 120 (1997) 1723-1737
12. Andersen P.M., Sims K.B., Xin W.W., Kiely R., O'Neill G., Ravits J., Pioro E., Harati Y., Brower R.D., Levine J.S., Heinicke H.U., Seltzer W., Boss M., and Brown Jr. R.H. Sixteen novel mutations in the Cu/Zn superoxide dismutase gene in amyotrophic lateral sclerosis: a decade of discoveries, defects and disputes. Amyotroph. Lateral Scler. Other Motor Neuron Disord 4 (2003) 62-73
13. Andrus P.K., Fleck T.J., Gurney M.E., and Hall E.D. Protein oxidative damage in a transgenic mouse model of familial amyotrophic lateral sclerosis. J. Neurochem 71 (1998) 2041-2048
14. Aoki M., Ogasawara M., Matsubara Y., Narisawa K., Nakamura S., Itoyama Y., and Abe K. Mild ALS in Japan associated with novel SOD mutation. Nat. Genet 5 (1993) 323-324
15. Aoki M., Ogasawara M., Matsubara Y., Narisawa K., Nakamura S., Itoyama Y., and Abe K. Familial amyotrophic lateral sclerosis (ALS) in Japan associated with H46R mutation in Cu/Zn superoxide dismutase gene: a possible new subtype of familial ALS. J. Neurol. Sci 126 (1994) 77-83
16. Aoki M., Lin C.L., Rothstein J.D., Geller B.A., Hosler B.A., Munsat T.L., Horvitz H.R., and Brown Jr. R.H. Mutations in the glutamate transporter EAAT2 gene do not cause abnormal EAAT2 transcripts in amyotrophic lateral sclerosis. Ann. Neurol 43 (1998) 645-653
17. Azari M.F., Galle A., Lopes E.C., Kurek J., and Cheema S.S. Leukemia inhibitory factor by systemic administration rescues spinal motor neurons in the SOD1 G93A murine model of familial amyotrophic lateral sclerosis. Brain Res 922 (2001) 144-147
18. Batulan Z., Shinder G.A., Minotti S., He B.P., Doroudchi M.M., Nalbantoglu J., Strong M.J., and Durham H.D. High threshold for induction of the stress response in motor neurons is associated with failure to activate HSF1. J. Neurosci 23 (2003) 5789-5798
19. Beal M.F., Ferrante R.J., Browne S.E., Matthews R.T., Kowall N.W., and Brown Jr. R.H. Increased 3-nitrotyrosine in both sporadic and familial amyotrophic lateral sclerosis. Ann. Neurol 42 (1997) 644-654
20. Beckman J.S., Carson M., Smith C.D., and Koppenol W.H. ALS, SOD and peroxynitrite. Nature 364 (1993) 584
21. Ben Hamida M., Hentati F., and Ben Hamida C. Hereditary motor system diseases (chronic juvenile amyotrophic lateral sclerosis). Conditions combining a bilateral pyramidal syndrome with limb and bulbar amyotrophy. Brain 113 (1990) 347-363
22. Bendotti C., Tortarolo M., Suchak S.K., Calvaresi N., Carvelli L., Bastone A., Rizzi M., Rattray M., and Mennini T. Transgenic SOD1 G93A mice develop reduced GLT-1 in spinal cord without alterations in cerebrospinal fluid glutamate levels. J. Neurochem 79 (2001) 737-746
23. Bogdanov M.B., Ramos L.E., Xu Z., and Beal M.F. Elevated "hydroxyl radical" generation in vivo in an animal model of amyotrophic lateral sclerosis. J. Neurochem 71 (1998) 1321-1324
24. Bonini N.M. Chaperoning brain degeneration. Proc. Natl Acad. Sci. USA 99 Suppl. 4 (2002) 16407-16411
25. Borchelt D.R., Wong P.C., Becher M.W., Pardo C.A., Lee M.K., Xu Z.S., Thinakaran G., Jenkins N.A., Copeland N.G., Sisodia S.S., Cleveland D.W., Price D.L., and Hoffman P.N. Axonal transport of mutant superoxide dismutase 1 and focal axonal abnormalities in the proximal axons of transgenic mice. Neurobiol. Dis 5 (1998) 27-35
26. Borgaonkar D.S., Schmidt L.C., Martin S.E., Kanzer M.D., Edelsohn L., Growdon J., and Farrer L.A. Linkage of late-onset Alzheimer's disease with apolipoprotein E type 4 on chromosome 19. Lancet 342 (1993) 625
27. Bowling A.C., Schulz J.B., Brown Jr. R.H., and Beal M.F. Superoxide dismutase activity, oxidative damage, and mitochondrial energy metabolism in familial and sporadic amyotrophic lateral sclerosis. J. Neurochem 61 (1993) 2322-2325
28. Bowling A.C., Barkowski E.E., McKenna-Yasek D., Sapp P., Horvitz H.R., Beal M.F., and Brown Jr. R.H. Superoxide dismutase concentration and activity in familial amyotrophic lateral sclerosis. J. Neurochem 64 (1995) 2366-2369
29. Brown Jr. R.H., and Robberecht W. Amyotrophic lateral sclerosis: pathogenesis. Semin. Neurol 21 (2001) 131-139
30. Bruening W., Roy J., Giasson B., Figlewicz D.A., Mushynski W.E., and Durham H.D. Up-regulation of protein chaperones preserves viability of cells expressing toxic Cu/Zn-superoxide dismutase mutants associated with amyotrophic lateral sclerosis. J. Neurochem 72 (1999) 693-699
31. Bruijn L.I., Beal M.F., Becher M.W., Schulz J.B., Wong P.C., Price D.L., and Cleveland D.W. Elevated free nitrotyrosine levels, but not protein-bound nitrotyrosine or hydroxyl radicals, throughout amyotrophic lateral sclerosis (ALS)-like disease implicate tyrosine nitration as an aberrant in vivo property of one familial ALS-linked superoxide dismutase 1 mutant. Proc. Natl Acad. Sci. USA 94 (1997) 7606-7611
32. Bruijn L.I., Becher M.W., Lee M.K., Anderson K.L., Jenkins N.A., Copeland N.G., Sisodia S.S., Rothstein J.D., Borchelt D.R., Price D.L., and Cleveland D.W. ALS-linked SOD1 mutant G85R mediates damage to astrocytes and promotes rapidly progressive disease with SOD1-containing inclusions. Neuron 18 (1997) 327-338
33. Bruijn L.I., Houseweart M.K., Kato S., Anderson K.L., Anderson S.D., Ohama E., Reaume A.G., Scott R.W., and Cleveland D.W. Aggregation and motor neuron toxicity of an ALS-linked SOD1 mutant independent from wild-type SOD1. Science 281 (1998) 1851-1854
34. Chance P.F., Rabin B.A., Ryan S.G., Ding Y., Scavina M., Crain B., Griffin J.W., and Cornblath D.R. Linkage of the gene for an autosomal dominant form of juvenile amyotrophic lateral sclerosis to chromosome 9q34. Am. J. Hum. Genet 62 (1998) 633-640
35. Chen Y.Z., Bennett C.L., Huynh H.M., Blair I.P., Puls I., Irobi J., Dierick I., Abel A., Kennerson M.L., Rabin B.A., Nicholson G.A., Auer-Grumbach M., Wagner K., De Jonghe P., Griffin J.W., Fischbeck K.H., Timmerman V., Cornblath D.R., and Chance P.F. DNA/RNA helicase gene mutations in a form of juvenile amyotrophic lateral sclerosis (ALS4). Am. J. Hum. Genet 74 (2004) 1128-1135
36. Chio A., Brignolio F., Meineri P., and Schiffer D. Phenotypic and genotypic heterogeneity of dominantly inherited amyotrophic lateral sclerosis. Acta. Neurol. Scand 75 (1987) 277-282
37. Cleveland D.W., and Rothstein J.D. From charcot to lou gehrig: deciphering selective motor neuron death in als. Nat. Rev. Neurosci 2 (2001) 806-819
38. Comi G.P., Bordoni A., Salani S., Franceschina L., Sciacco M., Prelle A., Fortunato F., Zeviani M., Napoli L., Bresolin N., Moggio M., Ausenda C.D., Taanman J.W., and Scarlato G. Cytochrome c oxidase subunit I microdeletion in a patient with motor neuron disease. Ann. Neurol 43 (1998) 110-116
39. Corcia P., Mayeux-Portas V., Khoris J., de Toffol B., Autret A., Muh J.P., Camu W., and Andres C. Abnormal SMN1 gene copy number is a susceptibility factor for amyotrophic lateral sclerosis. Ann. Neurol 51 (2002) 243-246
40. Corder E.H., Saunders A.M., Strittmatter W.J., Schmechel D.E., Gaskell P.C., Small G.W., Roses A.D., Haines J.L., and Pericak-Vance M.A. Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families. Science 261 (1993) 921-923
41. Cote F., Collard J.F., and Julien J.P. Progressive neuronopathy in transgenic mice expressing the human neurofilament heavy gene: a mouse model of amyotrophic lateral sclerosis. Cell 73 (1993) 35-46
42. Couillard-Despres S., Zhu Q., Wong P.C., Price D.L., Cleveland D.W., and Julien J.P. Protective effect of neurofilament heavy gene overexpression in motor neuron disease induced by mutant superoxide dismutase. Proc. Natl Acad. Sci. USA 95 (1998) 9626-9630
43. Crow J.P., Sampson J.B., Zhuang Y., Thompson J.A., and Beckman J.S. Decreased zinc affinity of amyotrophic lateral sclerosis-associated superoxide dismutase mutants leads to enhanced catalysis of tyrosine nitration by peroxynitrite. J. Neurochem 69 (1997) 1936-1944
44. Cudkowicz M.E., McKenna-Yasek D., Sapp P.E., Chin W., Geller B., Hayden D.L., Schoenfeld D.A., Hosler B.A., Horvitz H.R., and Brown R.H. Epidemiology of mutations in superoxide dismutase in amyotrophic lateral sclerosis. Ann. Neurol 41 (1997) 210-221
45. Cummings C.J., Sun Y., Opal P., Antalffy B., Mestril R., Orr H.T., Dillmann W.H., and Zoghbi H.Y. Over-expression of inducible HSP70 chaperone suppresses neuropathology and improves motor function in SCA1 mice. Hum. Mol. Genet 10 (2001) 1511-1518
46. Deng H.X., Hentati A., Tainer J.A., Iqbal Z., Cayabyab A., Hung W.Y., Getzoff E.D., Hu P., Herzfeldt B., Roos R.P., Warner C., Deng G., Soriano E., Smyth C., Parge H.E., Ahmed A., Roses A.D., Hallewell R.A., Pericak-Vance M.A., and Siddique T. Amyotrophic lateral sclerosis and structural defects in Cu,Zn superoxide dismutase. Science 261 (1993) 1047-1051
47. Devon R.S., Helm J.R., Rouleau G.A., Leitner Y., Lerman-Sagie T., Lev D., and Hayden M.R. The first non-sense mutation in alsin results in a homogeneous phenotype of infantile-onset ascending spastic paralysis with bulbar involvement in two siblings. Clin. Genet 64 (2003) 210-215
48. Durham H.D., Roy J., Dong L., and Figlewicz D.A. Aggregation of mutant Cu/Zn superoxide dismutase proteins in a culture model of ALS. J. Neuropathol. Exp. Neurol 56 (1997) 523-530
49. Estevez A.G., Crow J.P., Sampson J.B., Reiter C., Zhuang Y., Richardson G.J., Tarpey M.M., Barbeito L., and Beckman J.S. Induction of nitric oxide-dependent apoptosis in motor neurons by zinc- deficient superoxide dismutase. Science 286 (1999) 2498-2500
50. Evgrafov O.V., Mersiyanova I., Irobi J., Van Den Bosch L., Dierick I., Leung C.L., Schagina O., Verpoorten N., Van Impe K., Fedotov V., Dadali E., Auer-Grumbach M., Windpassinger C., Wagner K., Mitrovic Z., Hilton-Jones D., Talbot K., Martin J.J., Vasserman N., Tverskaya S., Polyakov A., Liem R.K., Gettemans J., Robberecht W., De Jonghe P., and Timmerman V. Mutant small heat-shock protein 27 causes axonal Charcot-Marie-Tooth disease and distal hereditary motor neuropathy. Nat Genet 36 (2004) 602-606
51. Eymard-Pierre E., Lesca G., Dollet S., Santorelli F.M., Di Capua M., Bertini E., and Boespflug-Tanguy O. Infantile-onset ascending hereditary spastic paralysis is associated with mutations in the alsin gene. Am. J. Hum. Genet 71 (2002) 518-527
52. Feeney S.J., Austin L., Bennett T.M., Kurek J.B., Jean-Francois M.J., Muldoon C., and Byrne E. The effect of leukaemia inhibitory factor on SOD1 G93A murine amyotrophic lateral sclerosis. Cytokine 23 (2003) 108-118
53. Ferrante R.J., Browne S.E., Shinobu L.A., Bowling A.C., Baik M.J., MacGarvey U., Kowall N.W., Brown Jr. R.H., and Beal M.F. Evidence of increased oxidative damage in both sporadic and familial amyotrophic lateral sclerosis. J. Neurochem 69 (1997) 2064-2074
54. Figlewicz D.A., Krizus A., Martinoli M.G., Meininger V., Dib M., Rouleau G.A., and Julien J.P. Variants of the heavy neurofilament subunit are associated with the development of amyotrophic lateral sclerosis. Hum. Mol. Genet 3 (1994) 1757-1761
55. Flowers J.M., Powell J.F., Leigh P.N., Andersen P., and Shaw C.E. Intron 7 retention and exon 9 skipping EAAT2 mRNA variants are not associated with amyotrophic lateral sclerosis. Ann. Neurol 49 (2001) 643-649
56. Forman H.J., and Fridovich I. On the stability of bovine superoxide dismutase. The effects of metals. J. Biol. Chem 248 (1973) 2645-2649
57. Fray A.E., Ince P.G., Banner S.J., Milton I.D., Usher P.A., Cookson M.R., and Shaw P.J. The expression of the glial glutamate transporter protein EAAT2 in motor neuron disease: an immunohistochemical study. Eur. J. Neurosci 10 (1998) 2481-2489
58. Fridovich I. Superoxide dismutases. Adv. Enzymol. Relat. Areas Mol. Biol 58 (1986) 61-97
59. Gallo J.M. Kennedy's disease: a triplet repeat disorder or a motor neuron disease?. Brain Res. Bull 56 (2001) 209-214
60. Giess R., Beck M., Goetz R., Nitsch R.M., Toyka K.V., and Sendtner M. Potential role of LIF as a modifier gene in the pathogenesis of amyotrophic lateral sclerosis. Neurology 54 (2000) 1003-1005
61. Graham A.J., Macdonald A.M., and Hawkes C.H. British motor neuron disease twin study. J. Neurol. Neurosurg. Psychiatry 62 (1997) 562-569
62. Gros-Louis F., Meijer I.A., Hand C.K., Dube M.P., MacGregor D.L., Seni M.H., Devon R.S., Hayden M.R., Andermann F., Andermann E., and Rouleau G.A. An ALS2 gene mutation causes hereditary spastic paraplegia in a Pakistani kindred. Ann. Neurol 53 (2003) 144-145
63. Gurney M.E., Pu H., Chiu A.Y., Dal Canto M.C., Polchow C.Y., Alexander D.D., Caliendo J., Hentati A., Kwon Y.W., Deng H.X., Chen W., Zhai P., Sufit R.L., and Siddique T. Motor neuron degeneration in mice that express a human Cu,Zn superoxide dismutase mutation. Science 264 (1994) 1772-1775
64. Hadano S., Hand C.K., Osuga H., Yanagisawa Y., Otomo A., Devon R.S., Miyamoto N., Showguchi-Miyata J., Okada Y., Singaraja R., Figlewicz D.A., Kwiatkowski T., Hosler B.A., Sagie T., Skaug J., Nasir J., Brown Jr. R.H., Scherer S.W., Rouleau G.A., Hayden M.R., and Ikeda J.E. A gene encoding a putative GTPase regulator is mutated in familial amyotrophic lateral sclerosis 2. Nat. Genet 29 (2001) 166-173
65. Hafezparast M., Klocke R., Ruhrberg C., Marquardt A., Ahmad-Annuar A., Bowen S., Lalli G., Witherden A.S., Hummerich H., Nicholson S., Morgan P.J., Oozageer R., Priestley J.V., Averill S., King V.R., Ball S., Peters J., Toda T., Yamamoto A., Hiraoka Y., Augustin M., Korthaus M., Wattler S., Wabnitz P., Dickneite C., Lampel S., Boehme F., Peraus G., Popp A., Rudelius M., Schlegel J., Fuchs H., Hrabe de Angelis M., Schiavo G., Shima D.T., Russ A.P., Stumm G., Martin J.E., and Fisher E.M. Mutations in dynein link motor neuron degeneration to defects in retrograde transport. Science 300 (2003) 808-812
66. Hall E.D., Andrus P.K., Oostveen J.A., Fleck T.J., and Gurney M.E. Relationship of oxygen radical-induced lipid peroxidative damage to disease onset and progression in a transgenic model of familial ALS. J. Neurosci. Res 53 (1998) 66-77
67. Hand C.K., Mayeux-Portas V., Khoris J., Briolotti V., Clavelou P., Camu W., and Rouleau G.A. Compound heterozygous D90A and D96N SOD1 mutations in a recessive amyotrophic lateral sclerosis family. Ann. Neurol 49 (2001) 267-271
68. Hand C.K., Khoris J., Salachas F., Gros-Louis F., Lopes A.A., Mayeux-Portas V., Brewer C.G., Brown Jr. R.H., Meininger V., Camu W., and Rouleau G.A. A novel locus for familial amyotrophic lateral sclerosis, on chromosome 18q. Am. J. Hum. Genet 70 (2002) 251-256
69. Hansen J.J., Durr A., Cournu-Rebeix I., Georgopoulos C., Ang D., Nielsen M.N., Davoine C.S., Brice A., Fontaine B., Gregersen N., and Bross P. Hereditary spastic paraplegia SPG13 is associated with a mutation in the gene encoding the mitochondrial chaperonin Hsp60. Am. J. Hum. Genet 70 (2002) 1328-1332
70. Haverkamp L.J., Appel V., and Appel S.H. Natural history of amyotrophic lateral sclerosis in a database population. Validation of a scoring system and a model for survival prediction. Brain 118 (1995) 707-719
71. Hayward C., Colville S., Swingler R.J., and Brock D.J. Molecular genetic analysis of the APEX nuclease gene in amyotrophic lateral sclerosis. Neurology 52 (1999) 1899-1901
72. Hentati A., Bejaoui K., Pericak-Vance M.A., Hentati F., Speer M.C., Hung W.Y., Figlewicz D.A., Haines J., Rimmler J., Ben Hamida C., Ben Hamida M., Brown Jr. R.H., and Siddique T. Linkage of recessive familial amyotrophic lateral sclerosis to chromosome 2q33-q35. Nat. Genet 7 (1994) 425-428
73. Hentati A., Ouahchi K., Pericak-Vance M.A., Nijhawan D., Ahmad A., Yang Y., Rimmler J., Hung W., Schlotter B., Ahmed A., Ben Hamida M., Hentati F., and Siddique T. Linkage of a commoner form of recessive amyotrophic lateral sclerosis to chromosome 15q15-q22 markers. Neurogenetics 2 (1998) 55-60
74. Hirano A., Kurland L.T., and Sayre G.P. Familial amyotrophic lateral sclerosis. A subgroup characterized by posterior and spinocerebellar tract involvement and hyaline inclusions in the anterior horn cells. Arch. Neurol 16 (1967) 232-243
75. Hosler B.A., Nicholson G.A., Sapp P.C., Chin W., Orrell R.W., de Belleroche J.S., Esteban J., Hayward L.J., McKenna-Yasek D., Yeung L., Cherryson A.K., Dench J.E., Wilton S.D., Laing N.G., Horvitz R.H., and Brown Jr. R.H. Three novel mutations and two variants in the gene for Cu/Zn superoxide dismutase in familial amyotrophic lateral sclerosis. Neuromuscul. Disord 6 (1996) 361-366
76. Hosler B.A., Siddique T., Sapp P.C., Sailor W., Huang M.C., Hossain A., Daube J.R., Nance M., Fan C., Kaplan J., Hung W.Y., McKenna-Yasek D., Haines J.L., Pericak-Vance M.A., Horvitz H.R., and Brown Jr. R.H. Linkage of familial amyotrophic lateral sclerosis with frontotemporal dementia to chromosome 9q21-q22. Jama 284 (2000) 1664-1669
77. Howland D.S., Liu J., She Y., Goad B., Maragakis N.J., Kim B., Erickson J., Kulik J., DeVito L., Psaltis G., DeGennaro L.J., Cleveland D.W., and Rothstein J.D. Focal loss of the glutamate transporter EAAT2 in a transgenic rat model of SOD1 mutant-mediated amyotrophic lateral sclerosis (ALS). Proc. Natl Acad. Sci. USA 99 (2002) 1604-1609
78. Husquinet H., and Franck G. Hereditary amyotrophic lateral sclerosis transmitted for five generations. Clin. Genet 18 (1980) 109-115
79. Hutton M., Lendon C.L., Rizzu P., Baker M., Froelich S., Houlden H., Pickering-Brown S., Chakraverty S., Isaacs A., Grover A., Hackett J., Adamson J., Lincoln S., Dickson D., Davies P., Petersen R.C., Stevens M., de Graaff E., Wauters E., van Baren J., Hillebrand M., Joosse M., Kwon J.M., Nowotny P., Che L.K., Norton J., Morris J.C., Reed L.A., Trojanowski J., Basun H., Lannfelt L., Neystat M., Fahn S., Dark F., Tannenberg T., Dodd P.R., Hayward N., Kwok J.B.J., Schofield P.R., Andreadis A., Snowden J., Craufurd D., Neary D., Owen F., Oostra B.A., Hardy J., Goate A., Van Swieten J., Mann D., Lynch T., and Heutink P. Association of missense and 5'-splice-site mutations in tau with the inherited dementia FTDP-17. Nature 393 (1998) 702-705
80. Imura T., Shimohama S., Kawamata J., and Kimura J. Genetic variation in the ciliary neurotrophic factor receptor alpha gene and familial amyotrophic lateral sclerosis. Ann. Neurol 43 (1998) 275
81. Irobi J., Van Impe K., Seeman P., Jordanova A., Dierick I., Verpoorten N., Michalik A., De Vriendt E., Jacobs A., Van Gerwen V., Vennekens K., Mazanec R., Tournev I., Hilton-Jones D., Talbot K., Kremensky I., Van Den Bosch L., Robberecht W., Van Vandekerckhove J., Broeckhoven C., Gettemans J., De Jonghe P., and Timmerman V. Hot-spot residue in small heat-shock protein 22 causes distal motor neuropathy. Nat. Genet 36 (2004) 597-601
82. Jackson M., Morrison K.E., Al-Chalabi A., Bakker M., and Leigh P.N. Analysis of chromosome 5q13 genes in amyotrophic lateral sclerosis: homozygous NAIP deletion in a sporadic case. Ann. Neurol 39 (1996) 796-800
83. Johnston J.A., Dalton M.J., Gurney M.E., and Kopito R.R. Formation of high molecular weight complexes of mutant Cu, Zn-superoxide dismutase in a mouse model for familial amyotrophic lateral sclerosis. Proc. Natl Acad. Sci. USA 97 (2000) 12571-12576
84. Jonsson P.A., Ernhill K., Andersen P.M., Bergemalm D., Brannstrom T., Gredal O., Nilsson P., and Marklund S.L. Minute quantities of misfolded mutant superoxide dismutase-1 cause amyotrophic lateral sclerosis. Brain 127 (2004) 73-88
85. Juneja T., Pericak-Vance M.A., Laing N.G., Dave S., and Siddique T. Prognosis in familial amyotrophic lateral sclerosis: progression and survival in patients with glu100gly and ala4val mutations in Cu,Zn superoxide dismutase. Neurology 48 (1997) 55-57
86. Kawata A., Kato S., Hayashi H., and Hirai S. Prominent sensory and autonomic disturbances in familial amyotrophic lateral sclerosis with a Gly93Ser mutation in the SOD1 gene. J. Neurol. Sci 153 (1997) 82-85
87. Kisby G.E., Milne J., and Sweatt C. Evidence of reduced DNA repair in amyotrophic lateral sclerosis brain tissue. Neuroreport 8 (1997) 1337-1340
88. Kobayashi Y., Kume A., Li M., Doyu M., Hata M., Ohtsuka K., and Sobue G. Chaperones Hsp70 and Hsp40 suppress aggregate formation and apoptosis in cultured neuronal cells expressing truncated androgen receptor protein with expanded polyglutamine tract. J. Biol. Chem 275 (2000) 8772-8778
89. Kong J., and Xu Z. Massive mitochondrial degeneration in motor neurons triggers the onset of amyotrophic lateral sclerosis in mice expressing a mutant SOD1. J. Neurosci 18 (1998) 3241-3250
90. Kong J., and Xu Z. Overexpression of neurofilament subunit NF-L and NF-H extends survival of a mouse model for amyotrophic lateral sclerosis. Neurosci. Lett 281 (2000) 72-74
91. Krobitsch S., and Lindquist S. Aggregation of huntingtin in yeast varies with the length of the polyglutamine expansion and the expression of chaperone proteins. Proc. Natl Acad. Sci. USA 97 (2000) 1589-1594
92. Kruman I.I., Pedersen W.A., Springer J.E., and Mattson M.P. ALS-linked Cu/Zn-SOD mutation increases vulnerability of motor neurons to excitotoxicity by a mechanism involving increased oxidative stress and perturbed calcium homeostasis. Exp. Neurol 160 (1999) 28-39
93. Lambrechts D., Storkebaum E., Morimoto M., Del-Favero J., Desmet F., Marklund S.L., Wyns S., Thijs V., Andersson J., van Marion I., Al-Chalabi A., Bornes S., Musson R., Hansen V., Beckman L., Adolfsson R., Pall H.S., Prats H., Vermeire S., Rutgeerts P., Katayama S., Awata T., Leigh N., Lang-Lazdunski L., Dewerchin M., Shaw C., Moons L., Vlietinck R., Morrison K.E., Robberecht W., Van Broeckhoven C., Collen D., Andersen P.M., and Carmeliet P. VEGF is a modifier of amyotrophic lateral sclerosis in mice and humans and protects motoneurons against ischemic death. Nat. Genet 34 (2003) 383-394
94. LaMonte B.H., Wallace K.E., Holloway B.A., Shelly S.S., Ascano J., Tokito M., Van Winkle T., Howland D.S., and Holzbaur E.L. Disruption of dynein/dynactin inhibits axonal transport in motor neurons causing late-onset progressive degeneration. Neuron 34 (2002) 715-727
95. Lefebvre S., Burglen L., Reboullet S., Clermont O., Burlet P., Viollet L., Benichou B., Cruaud C., Millasseau P., Zeviani M., Le Paslier D., Fre ́zal J., Cohen D., Weissenbach J., Munnich A., and Melki J. Identification and characterization of a spinal muscular atrophy- determining gene. Cell 80 (1995) 155-165
96. Levanon D., Lieman-Hurwitz J., Dafni N., Wigderson M., Sherman L., Bernstein Y., Laver-Rudich Z., Danciger E., Stein O., and Groner Y. Architecture and anatomy of the chromosomal locus in human chromosome 21 encoding the Cu/Zn superoxide dismutase. Embo. J 4 (1985) 77-84
97. Li T.M., Alberman E., and Swash M. Comparison of sporadic and familial disease amongst 580 cases of motor neuron disease. J. Neurol. Neurosurg. Psychiatry 51 (1988) 778-784
98. Lynch T., Sano M., Marder K.S., Bell K.L., Foster N.L., Defendini R.F., Sima A.A., Keohane C., Nygaard T.G., Fahn S., Mayeux R., Rowland L.P., and Wilhelmsen K.C. Clinical characteristics of a family with chromosome 17-linked disinhibition-dementia-parkinsonism-amyotrophy complex. Neurology 44 (1994) 1878-1884
99. Marklund S., Andersen P., Forsgren L., Nilsson L., Wikander G., and Öberg A. Normal binding and reactivity of copper in mutant superoxide dismutase isolated from amyotrophic lateral sclerosis patients. J. Neurochem 69 (1997) 675-681
100. Masu Y., Wolf E., Holtmann B., Sendtner M., Brem G., and Thoenen H. Disruption of the CNTF gene results in motor neuron degeneration. Nature 365 (1993) 27-32
101. Moulard B., Salachas F., Chassande B., Briolotti V., Meininger V., Malafosse A., and Camu W. Association between centromeric deletions of the SMN gene and sporadic adult-onset lower motor neuron disease. Ann. Neurol 43 (1998) 640-644
102. Mui S., Rebeck G.W., McKenna-Yasek D., Hyman B.T., and Brown Jr. R.H. Apolipoprotein E epsilon 4 allele is not associated with earlier age at onset in amyotrophic lateral sclerosis. Ann. Neurol 38 (1995) 460-463
103. Mulder D.W., Kurland L.T., Offord K.P., and Beard C.M. Familial adult motor neuron disease: amyotrophic lateral sclerosis. Neurology 36 (1986) 511-517
104. Olkowski Z.L. Mutant AP endonuclease in patients with amyotrophic lateral sclerosis. Neuroreport 9 (1998) 239-242
105. Oosthuyse B., Moons L., Storkebaum E., Beck H., Nuyens D., Brusselmans K., Van Dorpe J., Hellings P., Gorselink M., Heymans S., Theilmeier G., Dewerchin M., Laudenbach V., Vermylen P., Raat H., Acker T., Vleminckx V., Van Den Bosch L., Cashman N., Fujisawa H., Drost M.R., Sciot R., Bruyninckx F., Hicklin D.J., Ince C., Gressens P., Lupu F., Plate K.H., Robberecht W., Herbert J.M., Collen D., and Carmeliet P. Deletion of the hypoxia-response element in the vascular endothelial growth factor promoter causes motor neuron degeneration. Nat. Genet 28 (2001) 131-138
106. Orrell R.W., and Figlewicz D.A. Clinical implications of the genetics of ALS and other motor neuron diseases. Neurology 57 (2001) 9-17
107. Orrell R., de Belleroche J., Marklund S., Bowe F., and Hallewell R. A novel SOD mutant and ALS. Nature 374 (1995) 504-505
108. Orrell R.W., Marklund S.L., and deBelleroche J.S. Familial ALS is associated with mutations in all exons of SOD1: a novel mutation in exon 3 (Gly72Ser). J. Neurol. Sci 153 (1997) 46-49
109. Orrell R.W., Habgood J.J., de Belleroche J.S., and Lane R.J. The relationship of spinal muscular atrophy to motor neuron disease: investigation of SMN and NAIP gene deletions in sporadic and familial ALS. J. Neurol. Sci 145 (1997) 55-61
110. Orrell R.W., Habgood J.J., Gardiner I., King A.W., Bowe F.A., Hallewell R.A., Marklund S.L., Greenwood J., Lane R.J., and deBelleroche J. Clinical and functional investigation of 10 missense mutations and a novel frameshift insertion mutation of the gene for copper-zinc superoxide dismutase in UK families with amyotrophic lateral sclerosis. Neurology 48 (1997) 746-751
111. Parboosingh J.S., Rouleau G.A., Meninger V., McKenna-Yasek D., Brown Jr. R.H., and Figlewicz D.A. Absence of mutations in the Mn superoxide dismutase or catalase genes in familial amyotrophic lateral sclerosis. Neuromuscul. Disord 5 (1995) 7-10
112. Parboosingh J.S., Meininger V., McKenna-Yasek D., Brown Jr. R.H., and Rouleau G.A. Deletions causing spinal muscular atrophy do not predispose to amyotrophic lateral sclerosis. Arch. Neurol 56 (1999) 710-712
113. Pardo C.A., Xu Z., Borchelt D.R., Price D.L., Sisodia S.S., and Cleveland D.W. Superoxide dismutase is an abundant component in cell bodies, dendrites, and axons of motor neurons and in a subset of other neurons. Proc. Natl Acad. Sci. USA 92 (1995) 954-958
114. Parton M.J., Broom W., Andersen P.M., Al-Chalabi A., Nigel Leigh P., Powell J.F., and Shaw C.E. D90A-SOD1 mediated amyotrophic lateral sclerosis: a single founder for all cases with evidence for a Cis-acting disease modifier in the recessive haplotype. Hum. Mutat 20 (2002) 473
115. Pedersen W.A., Fu W., Keller J.N., Markesbery W.R., Appel S., Smith R.G., Kasarskis E., and Mattson M.P. Protein modification by the lipid peroxidation product 4-hydroxynonenal in the spinal cords of amyotrophic lateral sclerosis patients. Ann. Neurol 44 (1998) 819-824
116. Puls I., Jonnakuty C., LaMonte B.H., Holzbaur E.L., Tokito M., Mann E., Floeter M.K., Bidus K., Drayna D., Oh S.J., Brown Jr. R.H., Ludlow C.L., and Fischbeck K.H. Mutant dynactin in motor neuron disease. Nat. Genet 33 (2003) 455-456
117. Rabin B.A., Griffin J.W., Crain B.J., Scavina M., Chance P.F., and Cornblath D.R. Autosomal dominant juvenile amyotrophic lateral sclerosis. Brain 122 (1999) 1539-1550
118. Radunovic A., and Leigh P.N. Cu/Zn superoxide dismutase gene mutations in amyotrophic lateral sclerosis: correlation between genotype and clinical features. J. Neurol. Neurosurg. Psychiatry 61 (1996) 565-572
119. Rainero I., Pinessi L., Tsuda T., Vignocchi M.G., Vaula G., Calvi L., Cerrato P., Rossi B., Bergamini L., McLachlan D.R., and St. George-Hyslop P.H. SOD1 missense mutation in an Italian family with ALS. Neurology 44 (1994) 347-349
120. Reaume A.G., Elliott J.L., Hoffman E.K., Kowall N.W., Ferrante R.J., Siwek D.F., Wilcox H.M., Flood D.G., Beal M.F., Brown Jr. R.H., Scott R.W., and Snider W.D. Motor neurons in Cu/Zn superoxide dismutase-deficient mice develop normally but exhibit enhanced cell death after axonal injury. Nat. Genet 13 (1996) 43-47
121. Ripps M.E., Huntley G.W., Hof P.R., Morrison J.H., and Gordon J.W. Transgenic mice expressing an altered murine superoxide dismutase gene provide an animal model of amyotrophic lateral sclerosis. Proc. Natl Acad. Sci. USA 92 (1995) 689-693
122. Robberecht W. Genetics of Amyotrophic Lateral Sclerosis and Ethical Implications (2002), W.B.Saunders, London
123. Robberecht W., Sapp P., Viaene M.K., Rosen D., McKenna-Yasek D., Haines J., Horvitz R., Theys P., and Brown Jr. R. Cu/Zn superoxide dismutase activity in familial and sporadic amyotrophic lateral sclerosis. J. Neurochem 62 (1994) 384-387
124. Robberecht W., Aguirre T., Van Den Bosch L., Tilkin P., Cassiman J.J., and Matthijs G. D90A heterozygosity in the SOD1 gene is associated with familial and apparently sporadic amyotrophic lateral sclerosis. Neurology 47 (1996) 1336-1339
125. Rooke K., Figlewicz D.A., Han F.Y., and Rouleau G.A. Analysis of the KSP repeat of the neurofilament heavy subunit in familiar amyotrophic lateral sclerosis. Neurology 46 (1996) 789-790
126. Rosen D.R., Siddique T., Patterson D., Figlewicz D.A., Sapp P., Hentati A., Donaldson D., Goto J., O'Regan J.P., Deng H.X., Rahmani Z., Krizus A., McKenna-Yasek D., Cayabyab A., Gaston S.M., Berger R., Tanzi R.E., Halperin J.J., Herzfeldt B., Van den Bergh R., Hung W.Y., Bird T., Deng G., Mulder D.W., Smyth C., Laing N.G., Soriano E., Pericak-Vance M.A., Haines J., Rouleau G.A., Gusella S., Horvitz R., and Brown Jr. R.H. Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis. Nature 362 (1993) 59-62
127. Rosen D.R., Bowling A.C., Patterson D., Usdin T.B., Sapp P., Mezey E., McKenna-Yasek D., O'Regan J., Rahmani Z., Ferrante R.J., Brownstein M.J., Kowall N.W., Beal M.F., Horvitz H.R., and Brown Jr. H.R. A frequent ala 4 to val superoxide dismutase-1 mutation is associated with a rapidly progressive familial amyotrophic lateral sclerosis. Hum. Mol. Genet 3 (1994) 981-987
128. Rothstein J.D., Van Kammen M., Levey A.I., Martin L.J., and Kuncl R.W. Selective loss of glial glutamate transporter GLT-1 in amyotrophic lateral sclerosis. Ann. Neurol 38 (1995) 73-84
129. Rothstein J.D., Dykes-Hoberg M., Pardo C.A., Bristol L.A., Jin L., Kuncl R.W., Kanai Y., Hediger M.A., Wang Y., Schielke J.P., and Welty D.F. Knockout of glutamate transporters reveals a major role for astroglial transport in excitotoxicity and clearance of glutamate. Neuron 16 (1996) 675-686
130. Roy N., Mahadevan M.S., McLean M., Shutler G., Yaraghi Z., Farahani R., Baird S., Besner-Johnston A., Lefebvre C., Kang X., Salih M., Aubry H., Tamai K., Guan X., Ioannou P., Crawford T.O., de Jong P.J., Surh L., Ikeda J.E., Korneluk R.G., and MacKenzie A. The gene for neuronal apoptosis inhibitory protein is partially deleted in individuals with spinal muscular atrophy. Cell 80 (1995) 167-178
131. Ruddy D.M., Parton M.J., Al-Chalabi A., Lewis C.M., Vance C., Smith B.N., Leigh P.N., Powell J.F., Siddique T., Meyjes E.P., Baas F., de Jong V., and Shaw C.E. Two families with familial amyotrophic lateral sclerosis are linked to a novel locus on chromosome 16q. Am. J. Hum. Genet 73 (2003) 390-396
132. Sapp P.C., Hosler B.A., McKenna-Yasek D., Chin W., Gann A., Genise H., Gorenstein J., Huang M., Sailer W., Scheffler M., Valesky M., Haines J.L., Pericak-Vance M., Siddique T., Horvitz H.R., and Brown Jr. R.H. Identification of two novel loci for dominantly inherited familial amyotrophic lateral sclerosis. Am. J. Hum. Genet 73 (2003) 397-403
133. Sasaki S., Komori T., and Iwata M. Excitatory amino acid transporter 1 and 2 immunoreactivity in the spinal cord in amyotrophic lateral sclerosis. Acta. Neuropathol. (Berl) 100 (2000) 138-144
134. Shaw P.J., Ince P.G., Falkous G., and Mantle D. Oxidative damage to protein in sporadic motor neuron disease spinal cord. Ann. Neurol 38 (1995) 691-695
135. Shaw C.E., Enayat Z.E., Chioza B.A., Al-Chalabi A., Radunovic A., Powell J.F., and Leigh P.N. Mutations in all five exons of SOD-1 may cause ALS. Ann. Neurol 43 (1998) 390-394
136. Sherman M.Y., and Goldberg A.L. Cellular defenses against unfolded proteins: a cell biologist thinks about neurodegenerative diseases. Neuron 29 (2001) 15-32
137. Siddique N., Hong J.S., and Brooks B.J. X-linked dominant locus for late-onset familial amyotrophic lateral sclerosis. Am. J. Hum. Genet 63 (1998) A308
138. Siddique T., Pericak-Vance M.A., Caliendo J., Hong S.T., Hung W.Y., Kaplan J., McKenna-Yasek D., Rimmler J.B., Sapp P., Saunders A.M., Scott W.K., Siddique N., Haines J.L., and Brown R.H. Lack of association between apolipoprotein E genotype and sporadic amyotrophic lateral sclerosis. Neurogenetics 1 (1998) 213-216
139. Singh R.J., Karoui H., Gunther M.R., Beckman J.S., Mason R.P., and Kalyanaraman B. Reexamination of the mechanism of hydroxyl radical adducts formed from the reaction between familial amyotrophic lateral sclerosis-associated Cu,Zn superoxide dismutase mutants and H2O2. Proc. Natl Acad. Sci. USA 95 (1998) 6675-6680
140. Smith R.G., and Appel S.H. Molecular approaches to amyotrophic lateral sclerosis. Annu. Rev. Med 46 (1995) 133-145
141. Smith R.G., Haverkamp L.J., Case S., Appel V., and Appel S.H. Apolipoprotein E epsilon 4 in bulbar-onset motor neuron disease. Lancet 348 (1996) 334-335
142. Spillantini M.G., and Goedert M. Tau protein pathology in neurodegenerative diseases. Trends Neurosci 21 (1998) 428-433
143. Storkebaum, E, Lambrechts, D, Masafumi, M, Vanhoutte, G, Van der Linden, G, Collen, D, Baekelandt, V, Moons, L, Carmeliet, P (2003) VEGF, a modifier of motor neuron degeneration in SOD1 G93A mice, protects against motor neuron loss after spinal cord ischemia: evidence for a vascular hypothesis. Program No. 602.11. Abstract Viewer/Itinerary Planner. Washington, DC: Society for Neuroscience, 2003. Online.
144. Strong M.J., Hudson A.J., and Alvord W.G. Familial amyotrophic lateral sclerosis, 1850-1989: a statistical analysis of the world literature. Can. J. Neurol. Sci 18 (1991) 45-58
145. Subramaniam J.R., Lyons W.E., Liu J., Bartnikas T.B., Rothstein J., Price D.L., Cleveland D.W., Gitlin J.D., and Wong P.C. Mutant SOD1 causes motor neuron disease independent of copper chaperone-mediated copper loading. Nat. Neurosci 5 (2002) 301-307
146. Takahashi R., Yokoji H., Misawa H., Hayashi M., Hu J., and Deguchi T. A null mutation in the human CNTF gene is not causally related to neurological diseases. Nat. Genet 7 (1994) 79-84
147. Thijs V., Peeters E., Theys P., Matthijs G., and Robberecht W. Demographic characteristics and prognosis in a Flemish amyotrophic lateral sclerosis population. Acta. Neurol. Belg 100 (2000) 84-90
148. Tomblyn M., Kasarskis E.J., Xu Y., and St Clair D.K. Distribution of MnSOD polymorphisms in sporadic ALS patients. J. Mol. Neurosci 10 (1998) 65-66
149. Tomkins J., Banner S.J., McDermott C.J., and Shaw P.J. Mutation screening of manganese superoxide dismutase in amyotrophic lateral sclerosis. Neuroreport 12 (2001) 2319-2322
150. Tomkins J., Usher P., Slade J.Y., Ince P.G., Curtis A., Bushby K., and Shaw P.J. Novel insertion in the KSP region of the neurofilament heavy gene in amyotrophic lateral sclerosis (ALS). Neuroreport 9 (1998) 3967-3970
151. Trotti D., Rolfs A., Danbolt N.C., Brown Jr. R.H., and Hediger M.A. SOD1 mutants linked to amyotrophic lateral sclerosis selectively inactivate a glial glutamate transporter. Nat. Neurosci 2 (1999) 848
152. Trotti D., Aoki M., Pasinelli P., Berger U.V., Danbolt N.C., Brown Jr. R.H., and Hediger M.A. Amyotrophic lateral sclerosis-linked glutamate transporter mutant has impaired glutamate clearance capacity. J. Biol. Chem 276 (2001) 576-582
153. Valentine J.S., and Hart P.J. Misfolded CuZnSOD and amyotrophic lateral sclerosis. Proc. Natl Acad. Sci. USA 100 (2003) 3617-3622
154. Van Damme P., Van Den Bosch L., Van Houtte E., Callewaert G., and Robberecht W. GluR2-dependent properties of AMPA receptors determine the selective vulnerability of motor neurons to excitotoxicity. J. Neurophysiol 88 (2002) 1279-1287
155. Van Damme P., Leyssen M., Callewaert G., Robberecht W., and Van Den Bosch L. The AMPA receptor antagonist NBQX prolongs survival in a transgenic mouse model of amyotrophic lateral sclerosis. Neurosci. Lett 343 (2003) 81-84
156. Van Den Bosch L., Storkebaum E., Vleminckx V., Moons L., Vanopdenbosch L., Scheveneels W., Carmeliet P., and Robberecht W. Effect of vascular endothelial growth factor (VEGF) on motor neuron degeneration. Neurobiol. Dis 17 (2004) 21-28
157. Van Landeghem G.F., Tabatabaie P., Beckman G., Beckman L., and Andersen P.M. Manganese-containing superoxide dismutase signal sequence polymorphism associated with sporadic motor neuron disease. Eur. J. Neurol 6 (1999) 639-644
158. Vanopdenbosch L., and Robberecht W. Unusual phenotype with the G93C mutation in SOD1 in familial ALS. Neurology 56 (2001) A445
159. Vechio J.D., Bruijn L.I., Xu Z., Brown Jr. R.H., and Cleveland D.W. Sequence variants in human neurofilament proteins: absence of linkage to familial amyotrophic lateral sclerosis. Ann. Neurol 40 (1996) 603-610
160. Veldink J.H., van den Berg L.H., Cobben J.M., Stulp R.P., De Jong J.M., Vogels O.J., Baas F., Wokke J.H., and Scheffer H. Homozygous deletion of the survival motor neuron 2 gene is a prognostic factor in sporadic ALS. Neurology 56 (2001) 749-752
161. Veltema A.N., Roos R.A., and Bruyn G.W. Autosomal dominant adult amyotrophic lateral sclerosis. A six generation Dutch family. J. Neurol. Sci 97 (1990) 93-115
162. Vleminckx V., Van Damme P., Goffin K., Delye H., Van Den Bosch L., and Robberecht W. Upregulation of HSP27 in a transgenic model of ALS. J. Neuropathol. Exp. Neurol 61 (2002) 968-974
163. Wang J., Slunt H., Gonzales V., Fromholt D., Coonfield M., Copeland N.G., Jenkins N.A., and Borchelt D.R. Copper-binding-site-null SOD1 causes ALS in transgenic mice: aggregates of non-native SOD1 delineate a common feature. Hum. Mol. Genet 12 (2003) 2753-2764
164. Warrick J.M., Chan H.Y., Gray-Board G.L., Chai Y., Paulson H.L., and Bonini N.M. Suppression of polyglutamine-mediated neurodegeneration in Drosophila by the molecular chaperone HSP70. Nat. Genet 23 (1999) 425-428
165. Wiedau-Pazos M., Goto J.J., Rabizadeh S., Gralla E.B., Roe J.A., Lee M.K., Valentine J.S., and Bredesen D.E. Altered reactivity of superoxide dismutase in familial amyotrophic lateral sclerosis. Science 271 (1996) 515-518
166. Williams D.B., Floate D.A., and Leicester J. Familial motor neuron disease: differing penetrance in large pedigrees. J. Neurol. Sci 86 (1988) 215-230
167. Williamson T.L., and Cleveland D.W. Slowing of axonal transport is a very early event in the toxicity of ALS-linked SOD1 mutants to motor neurons. Nat. Neurosci 2 (1999) 50-56
168. Williamson T.L., Bruijn L.I., Zhu Q., Anderson K.L., Anderson S.D., Julien J.P., and Cleveland D.W. Absence of neurofilaments reduces the selectivevulnerability of motor neurons and slows disease caused by a familial amyotrophic lateral sclerosis-linked superoxide dismutase 1 mutant. Proc. Natl Acad. Sci. USA 95 (1998) 9631-9636
169. Wong P.C., Pardo C.A., Borchelt D.R., Lee M.K., Copeland N.G., Jenkins N.A., Sisodia S.S., Cleveland D.W., and Price D.L. An adverse property of a familial ALS-linked SOD1 mutation causes motor neuron disease characterized by vacuolar degeneration of mitochondria. Neuron 14 (1995) 1105-1116
170. Wong P.C., Rothstein J.D., and Price D.L. The genetic and molecular mechanisms of motor neuron disease. Curr. Opin. Neurobiol 8 (1998) 791-799
171. Xu Z., Cork L.C., Griffin J.W., and Cleveland D.W. Increased expression of neurofilament subunit NF-L produces morphological alterations that resemble the pathology of human motor neuron disease. Cell 73 (1993) 23-33
172. Yang Y., Hentati A., Deng H.X., Dabbagh O., Sasaki T., Hirano M., Hung W.Y., Ouahchi K., Yan J., Azim A.C., Cole N., Gascon G., Yagmour A., Ben-Hamida M., Pericak-Vance M., Hentati F., and Siddique T. The gene encoding alsin, a protein with three guanine-nucleotide exchange factor domains, is mutated in a form of recessive amyotrophic lateral sclerosis. Nat. Genet 29 (2001) 160-165
173. m for hydrogen peroxide. Proc. Natl Acad. Sci. USA 93 (1996) 5709-5714
174. m value. J. Biol. Chem 272 (1997) 8861-8863
175. Zhao C., Takita J., Tanaka Y., Setou M., Nakagawa T., Takeda S., Yang H.W., Terada S., Nakata T., Takei Y., Saito M., Tsuji S., Hayashi Y., and Hirokawa N. Charcot-Marie-Tooth disease type 2A caused by mutation in a microtubule motor KIF1Bbeta. Cell 105 (2001) 587-597